1. Home
  2. EVF vs VRCA Comparison

EVF vs VRCA Comparison

Compare EVF & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Senior Income Trust

EVF

Eaton Vance Senior Income Trust

N/A

Current Price

$4.84

Market Cap

90.3M

Sector

Finance

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

N/A

Current Price

$4.15

Market Cap

88.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVF
VRCA
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.3M
88.0M
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
EVF
VRCA
Price
$4.84
$4.15
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $13.83
AVG Volume (30 Days)
★ 68.7K
40.9K
Earning Date
01-01-0001
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$58.01
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 370.22
52 Week Low
$4.81
$3.28
52 Week High
$5.52
$9.82

Technical Indicators

Market Signals
Indicator
EVF
VRCA
Relative Strength Index (RSI) 42.29 41.90
Support Level $4.81 $4.25
Resistance Level $5.03 $4.97
Average True Range (ATR) 0.03 0.31
MACD 0.00 -0.01
Stochastic Oscillator 42.86 25.25

Price Performance

Historical Comparison
EVF
VRCA

About EVF Eaton Vance Senior Income Trust

Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: